Immunoblots using bovine antibody against Haemophilus somnus as the primary antibody consistently identified 
Immunoblots using bovine antibody against Haemophilus somnus as the primary antibody consistently identified 31-, 40-and 78-kDa proteins in Sarkosyl-insoluble extracts of H. somnus. A genomic library of H. somnus 8025 DNA was constructed in plasmid pUC19, and 45 recombinants expressed proteins which were recognized by bovine antiserum in Western blots (immunoblots). Ten of the recombinants expressing a protein caused the lysis of bovine erythrocytes. Restriction Haemophilus somnus is a small, pleomorphic, gram-negative coccobacillus with unclear taxonomic status. It was first described as the cause of thromboembolic meningoencephalitis, a serious disease of cattle characterized by incoordination, depression, thrombosis, and necrotizing vasculitis (18, 24) . The organism was later confirmed to cause other cattle diseases including pneumonia (1, 2) , abortion (23, 25) , infertility (25) , and septicemia (37) .
The mechanism of interaction of H. somnus with the host humoral immune system is unclear. Bactericidal activities were observed in antiserum raised against whole cells, sonicate, or protein antigens of H. somnus in the presence of complement or complement and leukocytes in vitro (39) . In one study, low bactericidal activities of sera against H. somnus were observed in the most-susceptible age groups (47) . However, another study reported loss of cattle with high agglutinating antibody titers in experimental challenge with a thromboembolic meningoencephalitis isolate of H. somnus (50) . H. somnus bacterins have been widely used in cattle to stimulate immunity, but their efficacy is sometimes questioned (32, 45) .
In the search for protective antigens of H. somnus, either challenge studies or analysis of the immunoreactivity of H. somnus antigens to convalescent-phase sera have been employed. Saline-extracted, outer-membrane-complex, and anionic antigens of H. somnus protected cattle from H. somnus challenge after two vaccinations (49) . Anionic antigens also protected cattle from a virulent pneumonic strain of H. somnus (40) . However, administration of anionic antigens combined with lipopolysaccharide interfered with protection, as measured by higher clinical and hispathological scores (40) . Convalescent-phase serum from cows with H. somnus-induced experimental abortion recognized 76-and 40-kDa antigens of H. somnus (10) . Protective (48) . The membrane was prehybridized at 42°C for 2 to 4 h and then hybridized for 24 h with the biotinylated probe at 42°C (43) . After hybridization, the nitrocellulose or nylon membrane was washed twice sequentially in the following solutions: 2x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate [pH 7 .0])-0.1% sodium dodecyl sulfate (SDS) for 2 min, 0.2x SSC-0.1% SDS for 2 min at room temperature, and 0.16x SSC-0.1% SDS for 15 min at 50°C, and briefly rinsed in 2x SSC-0.1% SDS at room temperature. The membrane was blotted in TBS (0.05 M Tris-0.2 M NaCI [pH 7.5]) containing 3% bovine serum albumin and probed with streptavidin-alkaline phosphatase conjugate (1:1,000; BRL). After being washed in TBS, reactive DNA was visualized by being incubated in 0.1 M Tris-0.1 M NaCI-50 mM MgCl2 (pH 9.5) containing 0.4% nitroblue tetrazolium chloride and 0.3% 5-bromo-4-chloro-3-indolylphosphate (BRL). For the probe, the 1.7-kb BgIII fragment separated on 1% agarose gel was purified by electroelution in dialysis tubing with a molecular mass cutoff of 12,000 to 14,000 (Baxter Diagnostics Inc., McGaw Park, Ill.) at 80 to 100 mA for 3 to 5 h (43). After precipitation, purified DNA was conjugated with photoactivable biotin (Clontech Laboratories, Inc., Palo Alto, Calif.).
Antisera. Rabbit antisera prepared against formalin-killed H. somnus 8025 were used to identify immunoreactive clones in colony blotting. Bovine antisera were provided by John Andrews, Iowa State University Veterinary Diagnostic Laboratory, Ames. These antisera were generated by inoculating cattle with either live H. somnus 156-83, a commercial bacterin, or an experimental bacterin. Calves were bled before and after immunization. Unless otherwise stated, all antibody was absorbed three times against live E. coli DH5a (pUC19) at 37°C. The same procedure was applied for serum absorption against H. somnus.
Colony blotting. Transformed bacterial colonies were transferred directly from agar plates onto dry nitrocellulose filters and lysed as described by Meyer et al. (33) . Blotting was done by the modified procedure of Hawkes et al. (20) . Briefly, filters were incubated with rabbit antiserum against H. somnus (diluted 1:400) at 37°C for 1 h, washed, and incubated with biotinylated goat anti-rabbit immunoglobulin G (BRL; diluted 1:2,000) for 45 min at room temperature. The filters were washed and incubated with streptavidinalkaline phosphatase conjugate (BRL) diluted 1:6,000. Immunoreactive transformants were visualized with 0.44% nitroblue tetrazolium chloride (BRL) and 0.33% 5-bromo4-chloro-3-indolylphosphate (BRL).
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) analysis. A modified Laemmli (28) procedure was used to sepa-rate proteins on discontinuous gels consisting of 4% stacking gels and 6 to 20% gradient or 14% resolving gels. Proteins with apparent molecular masses ranging from 14 to 200 kDa (BRL) were used as molecular mass standards. Bacteria were boiled in SDS gel-loading buffer by the procedure of Sambrook et al. (43) . After electrophoresis, proteins were stained with 0.1% Coomassie blue R250 (43) . For immunoblotting, antigens were transferred to a nitrocellulose filter immediately after SDS-PAGE.
Immunoblot analysis. Nitrocellulose sheets were blocked in TBST (TBS containing 0.1% Tween 20) containing 3% gelatin for 1 h at 37°C and incubated for 2 h at 37°C with bovine antiserum against live H. somnus diluted 1:100 in TBST containing 1% gelatin. The nitrocellulose sheets were incubated for 45 min with peroxidase-conjugated goat antibovine immunoglobulin G (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, Md.) diluted 1:500 in TBST containing 1% gelatin. Bound immunoglobulin G was visualized in TBS containing 0.05% 1-chloro-4-naphthol (Sigma), 16% methanol, and 0.08% hydrogen peroxide (Sigma).
Subcloning of the 1.7-kb BglII fragment and generation of deletion clones. BglII fragments purified by gel electroelution as described above were ligated into BamHI-digested and calf intestinal alkaline phosphatase-treated pUC19. E. coli DH5a was transformed and hemolytic recombinants were selected as described above. All recombinants containing a 1.7-kb BglII fragment were hemolytic. One of these clones, S4, was used to generate deletion clones by using ExolIl nuclease digestion as described by Sambrook et al. (43) . After gradual deletion with ExoIII, plasmids of various sizes were ligated, transformed into competent E. coli DH5a cells (BRL), and screened by growing on LB agar containing ampicillin (100 ,ug/ml). Approximate insert sizes were determined by comparing EcoRI-digested plasmid DNA of deletion clones with HindIII-digested lambda DNA (BRL) on a 0.75% agarose gel and by sequencing data. Deletion clones were stored in 40% glycerol at -80°C.
DNA sequencing. Sequence analysis of the 1.7-kb BglII fragment was performed by the dideoxy chain termination method of Sanger et al. (44) . Plasmid DNA from subclones and deletion clones were purified by using Qiagen columns as indicated by the manufacturer (Qiagen, Inc., Chatsworth, Calif. Nucleotide sequence accession number. The GenBank accession number for the 1,730-bp nucleotide sequence discussed below (see Fig. 8 Fig. 1 ). Some recombinant proteins including the 31-kDa protein (Fig. 1, lane D) comigrated with major H. somnus protein bands (Fig. 1) Fig. 4 . Because of the low-stringency conditions, slight cross-reactivity with pUC19 was noted. After digestion with BglII, plasmid pHSI38 had a 6.4-kb reactive fragment, whereas others (pHSI42, pHSI72) had a 1.7-kb reactive fragment. This agrees with the restriction map (Fig.  3 ) in which pHSI38 lacks one BglII site. Plasmids from recombinants expressing antigens with other molecular masses did not react with the probe. The approximate location of the pHSI94 insert relative to other inserts in the restriction map was confirmed by reactivity to two types of probes, the 1.7-kb BglII fragment and the 2-kb XhoI-BglII fragment (Fig. 3) . Plasmid pHSI94 (nonhemolytic) reacted only with the BglII probe, while plasmids of hemolytic clones HSI38, -109, and -121 reacted with both probes (data (Fig. 5) . However, no reactivity was found with genomic DNA from other hemolytic pathogens including A. pleuropneumoniae, M. bovis, hemolytic E. coli (T191), and P. haemolytica (Fig. 6) Table 2 ). All 3'-end deletion clones which contained at least 753 bp were hemolytic (Table 2) . Deletion clones D27 and D33 lost immunoreactivity although they still retained hemolytic activity. Recombinant HSI94 which did not possess 620 bp of the 5' end of the BglII fragment was not hemolytic although it contained the rest of the BglII fragment. Immunoreactivity was present in deletion clones having at least 1,228 bp as well as in recombinant HSI94 (Table 2) . (14, 22) , while the majority of isolates produce incomplete lysis. The 31-kDa antigen caused com-plete hemolysis when expressed in E. coli, although H. somnus 8025 from which the 31-kDa antigen gene originated produced incomplete hemolysis. According to Southern blot, the 31-kDa antigen gene is present in a single copy in H. somnus 8025 and the apparent discrepancy may be due to higher expression in the recombinants. There have been no reports on the possible association of hemolytic activity and virulence in H. somnus. Whether the 31-kDa protein is highly expressed in vivo and causes increased virulence is not known. In addition to possible hemolytic activity, the 31-kDa antigen might express cytotoxic or inhibitory effects on cells of the immune system as do some hemolysins (26, 27, 41) . The cytotoxic effect ofH. somnus on bovine alveolar macrophages and bovine endothelial cells has been reported, although the responsible factor(s) was unidentified (31, 52 (9, 46) . It is also difficult to isolate the organism because of overgrowth by other bacteria as well as prior antibiotic treatment in most cattle with respiratory disease. Serological tests including agglutination, complement fixation, and hemagglutination have cross-reactivities with a broad range of bacteria (9, 46) . However, relatively high specificity was observed in an enzyme-linked immunosorbent assay (ELISA) when a soluble antigen ofH. somnus was used (9) . A coagglutination test with monoclonal antibody against the 46-kDa band of H. somnus differentiated H. somnus from Actinobacillus suis, Actinobacillus equuli, P. haemolytica, and Pasteurella multocida (53) . Since strong reactivity to relatively small amounts of 31-kDa antigen was observed with antiserum against H. somnus on immunoblot, monoclonal antibody against 31-kDa antigen might give additional specificity in an ELISA. Detection of H. somnus in tissue sections would be very useful because of difficulties in recovering the organism on culture. Detection in tissues might be simplified by using DNA probes. Tests using DNA probes have many advantages. They do not require specific antigen expression, the presence of large numbers of bacteria, or pure cultures (51) . The use of a portion of a virulence gene (34) or of a restriction fragment of chromosomal DNA (12) as a diagnostic probe has worked well with other pathogenic bacteria. The 1.7-kb probe may be useful as a diagnostic probe because it discriminated H. somnus from other pathogens such as P. haemolytica, A. pleuropneumoniae, hemolytic E. coli, and M. bovis. The absence of homology between the hly gene of A. pleuropneumoniae and genomic DNA of H. somnus has been reported previously (30) .
An amino acid sequence deduced from the 822-bp ORF was compared with that of other proteins. Carboxy-terminal ends of the deduced amino acid sequence had homology with C-terminal ends of a variety of proteins, including the periplasmic portion of outer membrane protein (OmpA) in E. coli (4, 7), S. dysenteriae (6) , and S. typhimurium (13), P6 of H. influenzae (36) , and PIII in N. gonorrhoeae (17) . The homologous region between PIII of N. gonorrhoeae and OmpA ofE. coli which was reported previously (17) includes the region of homology with the 31-kDa protein of H. somnus. The contribution of E. coli OmpA and PIII in N. gonorrhoeae to pathogenicity has been proposed (42, 54) . Also, the protective role of antibody against P6 to H. influenzae has been proposed (35) . However, whether this homology to the 31-kDa protein indicates functional importance or structural similarity is unclear.
The location of the 31-kDa protein in the bacterial cell wall has not been identified. The portion of OmpA homologous with the 31-kDa protein is located in the periplasmic layer (7) , and it is possible that the 31-kDa protein is similarly located in H. somnus.
